18F-FDG PET for evaluation of bone marrow infiltration in staging of lymphoma: a meta-analysis.pdf
- 1、本文档共6页,可阅读全部内容。
- 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
- 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载。
- 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
查看更多
18F-FDG PET for evaluation of bone marrow infiltration in staging of lymphoma: a meta-analysis
18F-FDG PET for Evaluation of Bone Marrow
Infiltration in Staging of Lymphoma:
A Meta-Analysis
Emilios E. Pakos, MD1; Andreas D. Fotopoulos, MD2; and John P.A. Ioannidis, MD1,3,4
1Clinical and Molecular Epidemiology Unit, Department of Hygiene and Epidemiology, University of Ioannina School of Medicine,
Ioannina, Greece; 2Department of Nuclear Medicine, University Hospital of Ioannina, School of Medicine, Ioannina, Greece;
3Biomedical Research Institute, Foundation for Research and Technology–Hellas, Ioannina, Greece; and 4Department of Medicine,
Institute for Clinical Research and Health Policy Studies, Tufts–New England Medical Center, Tufts University School of Medicine,
Boston, Massachusetts
The ability of PET with 18F-FDG to evaluate bone marrow infil-
tration in patients with lymphoma has been a matter of exten-
sive investigation with controversial results. Therefore, we
aimed to evaluate systematically, with a meta-analysis, the di-
agnostic performance of 18F-FDG PET in this setting. Methods:
Relevant studies were identified with MEDLINE and EMBASE
searches (last update, August 2004). Data on the diagnostic
performance of 18F-FDG PET were combined quantitatively
across eligible studies. We estimated weighted summary sen-
sitivities and specificities, summary receiver-operating-charac-
teristic (SROC) curves, and weighted summary likelihood ratios.
We also conducted separate analyses according to various
subgroups. Bone marrow biopsy (BMB) was used as the refer-
ence standard. Results: Thirteen eligible nonoverlapping stud-
ies, which enrolled a total of 587 patients, were included in the
meta-analysis. The independent random-effects weighted esti-
mates of sensitivity and specificity against BMB were 51%
(95% confidence interval [CI], 38%–64%) and 91% (95% CI,
85%–95%), respectively. Results were consistent in the SROC
curve: a sensitivity of 51% corresponds to a specificity of 92%,
whereas a specificity of 91% corresponds to a sensitivity of
55%. The weigh
您可能关注的文档
- %Krause ICML2010 - Submodular dictionary selection for sparse representation.pdf
- (ISP图的画法可参考)等电点沉淀法回收蛋白的特性.pdf
- (MX-GC控制柜)).pdf
- (ppt) IBM Content Based Copy Detection System for TRECVID 2009.pdf
- (ppt)BEA Weblogic Server8.1 Web Service.pdf
- (Reactive Violet 5R) decolorising native acclimatised bacterial consortia.pdf
- (universal.pdf
- (全6章)HL7 v3基础 Foundation完整版.pdf
- (初三英语测试题二).doc
- (天泉多级泵样本)TDLF-27p.pdf
文档评论(0)